Search
for
Sort by
Research 91–120 of 1000+
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Janus kinase inhibitors for alopecia areata: A narrative review
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Ritlecitinib: First Approval
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Expression Profiles of Tyrosine Kinases in Cultured Follicular Papilla Cells Versus Dermal Fibroblasts
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Modern Management Approaches for Alopecia Areata
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Hair Follicle Reconstruction and Stem Cells
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Protein Kinase C δ Overexpressing Transgenic Mice Are Resistant to Chemically but not to UV Radiation–Induced Development of Squamous Cell Carcinomas: A Possible Link to Specific Cytokines and Cyclooxygenase-2
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Comparative analysis of stemness between dermal papilla cells and human dermalstem/progenitor cells